0001104659-21-045101.txt : 20210401 0001104659-21-045101.hdr.sgml : 20210401 20210401060516 ACCESSION NUMBER: 0001104659-21-045101 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210430 FILED AS OF DATE: 20210401 DATE AS OF CHANGE: 20210401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AnPac Bio-Medical Science Co., Ltd. CENTRAL INDEX KEY: 0001786511 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39137 FILM NUMBER: 21795905 BUSINESS ADDRESS: STREET 1: 801 BIXING STREET STREET 2: BIHU COUNTY CITY: LISHUI, ZHEJIANG PROVINCE STATE: F4 ZIP: 323006 BUSINESS PHONE: 8657820516666 MAIL ADDRESS: STREET 1: 801 BIXING STREET STREET 2: BIHU COUNTY CITY: LISHUI, ZHEJIANG PROVINCE STATE: F4 ZIP: 323006 6-K 1 a21-11855_16k.htm 6-K

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of April 2021

 

Commission File Number: 001-39137

 

AnPac Bio-Medical Science Co., Ltd.

(Registrant’s name)

 

801 Bixing Street, Bihu County

Lishui, Zhejiang Province 323006

The People’s Republic of China
(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x  Form 40-F o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7): o

 

 

 

 

On February 21, 2021, AnPac Bio-Medical Science Co., Ltd. (the “Company” or “we”) entered into a share subscription agreement with a Chinese investor (the “investor”), under which the Company would issue, and the investor would acquire, a number of Class A ordinary shares in the Company for consideration of RMB12 million at a purchase price of US$4.8 per share. The Company issued 387,597 Class A ordinary Shares to the investor on February 24, 2021 according to the subscription agreement, based on an exchange rate of RMB6.45 to US$1.00, and in return, the Company received the consideration in full on March 18, 2021. We paid a finder’s fee in the form of 19,174 Class A ordinary shares to a Chinese consultant on March 22, 2021 in connection with this transaction.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

AnPac Bio-Medical Science Co., Ltd.

 

 

(Registrant)

 

 

 

 

 

 

Date: April 1, 2021

By:

/s/ Chris Chang Yu

 

Name:

Dr. Chris Chang Yu

 

Title:

Chairman of the Board of Directors
and Chief Executive Officer

 

3